| A Phase 1 Study to Evaluate MEDI6383 Alone and in Combination With MEDI4736 in Adult Subjects With Select Advanced Solid Tumors (NCT02221960) | MedImmune LLC | 2014-09-15 |
| Safety and Causal Prophylactic Efficacy of KAF156 in a Controlled Human Malaria Challenge Model (NCT04072302) | Novartis Pharmaceuticals | 2014-09-15 |
| A Phase 1 Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes Mellitus (NCT02211261) | Pfizer | 2014-09-15 |
| Effect of Sapanisertib (MLN0128) on the QTc Interval in Participants With Advanced Solid Tumors (NCT02197572) | Calithera Biosciences, Inc | 2014-09-15 |
| Ibrutinib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (NCT02219737) | National Cancer Institute (NCI) | 2014-09-12 |
| DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors (NCT02197169) | DNAtrix, Inc. | 2014-09-11 |
| An Open-Label Study of a Novel JAK-inhibitor, INCB052793, Given to Patients With Advanced Malignancies (NCT02265510) | Incyte Corporation | 2014-09-10 |
| A Study of Irinotecan Hydrochloride Liposome in Advanced Solid Tumors (NCT05086822) | Jiangsu HengRui Medicine Co., Ltd. | 2014-09-09 |
| Macrophage Markers, Soluble CD163 (sCD163) and Soluble CD206 (sCD206) in Paracetamol Overdose (NCT03679442) | University of Aarhus | 2014-09-08 |
| Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) (NCT02009488) | Janssen Research & Development, LLC | 2014-09-08 |
| Pharmacokinetic Study of Intravitreal Aflibercept Injection in Eyes With Wet Age-related Macular Degeneration (NCT02204683) | University of Nebraska | 2014-09-05 |
| Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast Cancer (NCT02139358) | H. Lee Moffitt Cancer Center and Research Institute | 2014-09-05 |
| A Dose-regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oratecan in Subjects With Advanced Malignancies (NCT02250157) | Athenex, Inc. | 2014-09-05 |
| Study on Pharmacokinetics (NCT02234882) | ViiV Healthcare | 2014-09-05 |
| Phase 1 Randomized Double-blind Placebo Controlled Study to Evaluate Safety and PK of MEDI3902 in Healthy Adults (NCT02255760) | MedImmune LLC | 2014-09-04 |
| Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects (NCT02235961) | Novo Nordisk A/S | 2014-09-04 |
| Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral Disorder (NCT02247986) | National Institute of Mental Health (NIMH) | 2014-09-04 |
| Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Participants With Muscular Dystrophy (NCT02239224) | aTyr Pharma, Inc. | 2014-09-04 |
| Evaluation of a Laparoscopic High Intensity Focused Ultrasound Probe for the Ablation of Small Renal Masses (NCT02248389) | Indiana University | 2014-09-04 |
| Study of the Safety and Pharmacokinetics of BGB-3111 in Subjects With B-Cell Lymphoid Malignancies (NCT02343120) | BeiGene | 2014-09-04 |
| Pharmacokinetics of BI 409306 After a High Fat, High Caloric Meal and After a Single Oral Dose Given at Bed Time in Healthy Volunteers (NCT02222168) | Boehringer Ingelheim | 2014-09-04 |
| Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections (NCT02231853) | National Heart, Lung, and Blood Institute (NHLBI) | 2014-09-03 |
| Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma (NCT01675765) | Aduro Biotech, Inc. | 2014-09-03 |
| Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum (NCT02054104) | National Cancer Institute (NCI) | 2014-09-03 |
| TEG Anticoagulation Monitoring During ECMO (NCT02271126) | Policlinico Hospital | 2014-09-02 |
| Study to Investigate the Safety and Activity of Aldoxorubicin Plus Ifosfamide/Mesna in Subjects With Metastatic Soft Tissue Sarcoma (NCT02235701) | ImmunityBio, Inc. | 2014-09-02 |
| A Phase I/II Study of Intratumoral Injection of SD-101 (NCT02254772) | Robert Lowsky | 2014-09-01 |
| Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Spinal Cord Injury (NCT01833975) | Chaitanya Hospital, Pune | 2014-09-01 |
| Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE) (NCT02244502) | NovoCure Ltd. | 2014-09-01 |
| Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children (NCT02237209) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-09-01 |
| Safety, Pharmacokinetic and Pharmacodynamic Study of the CDK 4/6 Inhibitor G1T28-1 (NCT02243150) | G1 Therapeutics, Inc. | 2014-09-01 |
| The Drug-drug Interaction of SHR3824 and Metformin (NCT02354027) | Jiangsu HengRui Medicine Co., Ltd. | 2014-09-01 |
| To Evaluate the Effect of Clarithromycin on the Systemic Exposure of Pacritinib in Healthy Subjects (NCT02807051) | CTI BioPharma | 2014-09-01 |
| Drug-Drug Interaction Study With AZD9291 and Omeprazole in Healthy Volunteers (NCT02224053) | AstraZeneca | 2014-09-01 |
| Evaluation of Consumption Safety and Effect of Mulberry Leaves and Vietnamese Coriander Based Instant Polyherbal Porridge on Working Memory and Bone Formation Markers (NCT02562274) | Khon Kaen University | 2014-09-01 |
| Mass Balance Study of MT-1303 (NCT02293967) | Tanabe Pharma Corporation | 2014-09-01 |
| Selumetinib in Combination With Gefitinib in NSCLC Patients (NCT02025114) | National Taiwan University Hospital | 2014-09-01 |
| Pharmacokinetic Study of Subcutaneous Testosterone Enanthate (NCT02233751) | Antares Pharma Inc. | 2014-09-01 |
| A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b (NCT02279433) | Nuvation Bio Inc. | 2014-09-01 |
| Study To Compare Single Dose Of Three Modified Release Formulations Of PF-04937319 With Immediate Release Material-Sparing-Tablet (IR MST) Formulation Previously Studied In Adults With Type 2 Diabetes Mellitus. (NCT02206607) | Pfizer | 2014-09-01 |
| Safety and Efficacy of Bone Marrow Derived MNCs for Treatment of Cells for the Treatment of Hunting Tons Chorea. (NCT01834053) | Chaitanya Hospital, Pune | 2014-09-01 |
| A Healthy Volunteer Trial to Gain Information About the Blood Concentrations of PF-06412562 After Oral Administration of a Modified Release Formulation in Fasted and Fed Conditions (NCT02201511) | Pfizer | 2014-09-01 |
| The Pharmacokinetic Study of the Fixed-dose Combination of Micronized Fenofibrate and Pitavastatin Ca (NCT02250976) | Hanlim Pharm. Co., Ltd. | 2014-09-01 |
| Effects of Glucagon Administration on Energy Expenditure (NCT02237053) | AdventHealth Translational Research Institute | 2014-09-01 |
| A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Autism (NCT01836562) | Chaitanya Hospital, Pune | 2014-09-01 |
| Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release Compared With Mono Compound Tablets in Healthy Subjects (NCT02230995) | Boehringer Ingelheim | 2014-09-01 |
| Biological Effect of Nab-paclitaxel Combined to Gemcitabine in Metastatic Pancreatic Cancer (NCT02174887) | Institut Paoli-Calmettes | 2014-09-01 |
| C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI (NCT02134314) | Cedars-Sinai Medical Center | 2014-09-01 |
| Safety Study of Human MUC-1 (Mucin-1) Adenoviral Vector Vaccine for Immunotherapy of Epithelial Cancers (NCT02140996) | Singapore Clinical Research Institute | 2014-09-01 |
| Pharmacokinetics of Delafloxacin in Subjects With and Without Hepatic Impairment (NCT02245243) | Melinta Therapeutics, Inc. | 2014-09-01 |
| Evaluation of Allium Ampeloprasum Spp.Iranicum Cream Effect for the Management of Hemorrhoids Symptoms (NCT02301052) | Shiraz University of Medical Sciences | 2014-09-01 |
| Assess Bioequivalence of Two Formulations of Doxorubicin Hydrochloride Liposome in Female Patients With Ovarian Cancer (NCT02237690) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2014-09-01 |
| Nanosilver Fluoride to Prevent Dental Biofilms Growth (NCT01950546) | University of Pernambuco | 2014-09-01 |
| Pharmacokinetic Study of Single Doses of ORM-12741 (NCT02319057) | Orion Corporation, Orion Pharma | 2014-09-01 |
| Effect of Brazilian Fruits Peel on Metabolic Regulation and Appetite in Healthy Subjects (NCT02245906) | Lund University | 2014-09-01 |
| Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD) (NCT02235844) | Allergy and Asthma Consultants, Wichita, Kansas | 2014-09-01 |
| Less Neuropathy After Yoga- Managing Diabetic Neuropathy With Yoga (NCT02659007) | Colorado State University | 2014-09-01 |
| Phase 1 Study of ACE-083 in Healthy Subjects (NCT02257489) | Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | 2014-09-01 |
| PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian Cancer (NCT02055690) | The Christie NHS Foundation Trust | 2014-09-01 |
| Skin Safety Study to Evaluate the Irritation Potential in Healthy Volunteers (NCT02227069) | Maruho North America Inc. | 2014-09-01 |
| Brain Imaging of Intranasal Oxytocin Treatment in Autism (NCT01945957) | University of North Carolina, Chapel Hill | 2014-09-01 |
| UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells (NCT02254863) | Joanne Kurtzberg, MD | 2014-09-01 |
| Confocal Laser Endomicroscopy for Brain Tumors (NCT02240758) | Hospices Civils de Lyon | 2014-09-01 |
| Phase I/II Trial of ATRA and TCP in Patients With Relapsed or Refractory AML and no Intensive Treatment is Possible (NCT02261779) | Martin-Luther-Universität Halle-Wittenberg | 2014-09-01 |
| Dose Escalation Study of LGH447 in Japanese Patients With Relapsed and/or Refractory Hematologic Malignancies (NCT02160951) | Novartis Pharmaceuticals | 2014-09-01 |
| Effect of Metformin Therapy on Serum Under-carboxylated Osteocalcin Levels in Hyperandrogenic Lean Polycystic Ovarian Syndrome Women (NCT02244567) | Beni-Suef University | 2014-09-01 |
| Bioequivalence Study of Two Different Formulations of N-acetyl-cysteine (NAC) (NCT02265224) | Zambon SpA | 2014-09-01 |
| Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDS) on Acclimatization to High Altitude (NCT02233582) | University of California, San Francisco | 2014-09-01 |
| Phase IB Trial of LDE225 and Paclitaxel in Recurrent Ovarian Cancer (NCT02195973) | University of Alabama at Birmingham | 2014-09-01 |
| CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma (NCT02168140) | Wake Forest University Health Sciences | 2014-09-01 |
| Explore the Synergy of Combination TKI Therapy (NCT02129166) | University of Florida | 2014-09-01 |
| Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Muscular Dystrophy. (NCT01834066) | Chaitanya Hospital, Pune | 2014-09-01 |
| VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors (NCT02146222) | University of Wisconsin, Madison | 2014-09-01 |
| A Study To Evaluate D1 Receptor Occupancy (RO) Following Single Dose of PF-06412562 In Healthy Male Volunteers (NCT02124213) | Pfizer | 2014-09-01 |
| Effects of Fun Physical Activity on the Interest to Daily Physical Activity and Sarcopenia of Elderly People (NCT02259673) | Mashhad University of Medical Sciences | 2014-09-01 |
| A Study to Assess Effect of JNJ-54861911 on Pharmacokinetics of Cocktail Representatives for Cytochrome P450 (CYP) 3A4, CYP2B6, CYP2C9, and CYP1A2 Substrates (NCT02211079) | Janssen Research & Development, LLC | 2014-09-01 |
| Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral T-cell Lymphomas (NCT02223208) | Fondazione Italiana Linfomi - ETS | 2014-09-01 |
| PET-CT Imaging of Neuro-endocrine Tumors and Preliminary Clinical Evaluation (NCT02134639) | University Hospital, Bordeaux | 2014-09-01 |
| A Study To Evaluate The Safety And Tolerability Of PF-06342674 (RN168) In Subjects With Multiple Sclerosis (MS) (NCT02045732) | Pfizer | 2014-09-01 |
| Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome (NCT02256475) | Neurocrine Biosciences | 2014-09-01 |
| MSC for Treatment of Interstitial Lung Disease After Allo-HSCT (NCT02543073) | Nanfang Hospital, Southern Medical University | 2014-09-01 |
| Efficacy of Propolis Varnish Against Oral Biofilm (NCT02052973) | Federal University of Minas Gerais | 2014-09-01 |
| Wound Treatment With 3% Sodium Pentaborate Pentahydrate (NCT02241811) | SB Istanbul Education and Research Hospital | 2014-09-01 |
| Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children (NCT02040831) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-09-01 |
| Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer (NCT02174549) | Teclison Ltd. | 2014-09-01 |
| rESP Medication With a Single Intravenous Administration and Dose Escalation to Explore the Tolerability ,Safety and Pharmacokinetic Characteristics (NCT02356419) | Shenyang Sunshine Pharmaceutical Co., LTD. | 2014-09-01 |
| Study to Evaluate the Safety, Pharmacokinetics and Target Engagement of BMS-986142 in Healthy Subjects (NCT02257151) | Bristol-Myers Squibb | 2014-09-01 |
| PTX-200 and Carboplatin in Ovarian Cancer (NCT01690468) | Prescient Therapeutics, Ltd. | 2014-09-01 |
| Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery: Proposal for Pilot Investigation (NCT02519335) | Medical City Children's Hospital | 2014-09-01 |
| CKD-397 Drug-drug Interaction Study (B) (NCT02247505) | Chong Kun Dang Pharmaceutical | 2014-09-01 |
| New Therapeutic Perspectives in Obesity (NCT02153021) | Universidade Federal de Sao Carlos | 2014-09-01 |
| A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70 (NCT01985087) | University of Louisville | 2014-09-01 |
| Study to Determine and Compare Plasma and Intrapulmonary Pharmacokinetics of WCK 2349 in Healthy Adult Human Subjects (NCT02253342) | Wockhardt | 2014-09-01 |
| To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer (NCT02093351) | AstraZeneca | 2014-09-01 |
| Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular Dystrophy (NCT01834040) | Chaitanya Hospital, Pune | 2014-09-01 |
| A Phase I Study of TAS-102 in Solid Tumors (NCT02261532) | Taiho Pharmaceutical Co., Ltd. | 2014-09-01 |
| Selinexor Combination Ph 1 Study (NCT05177276) | Martin Gutierrez | 2014-09-01 |
| Phase I Studies of Chlorogenic Acid for Injection for Tolerance and Pharmacokinetic of Advanced Cancers (NCT02245204) | Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd | 2014-09-01 |
| Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy (NCT02058550) | Stanford University | 2014-09-01 |
| Intestinal Microflora in Lung Cancer After Chemotherapy (NCT02771470) | Shandong University | 2014-09-01 |